BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1576941)

  • 1. [Classical and new hemostasis risk factors in coronary disease].
    Willich SN
    Dtsch Med Wochenschr; 1992 May; 117(19):749-56. PubMed ID: 1576941
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus, vascular disease and thrombosis.
    Banga JD; Sixma JJ
    Clin Haematol; 1986 May; 15(2):465-92. PubMed ID: 3524933
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina.
    Lowe GD; Wood DA; Douglas JT; Riemersma RA; Macintyre CC; Takase T; Tuddenham EG; Forbes CD; Elton RA; Oliver MF
    Thromb Haemost; 1991 Apr; 65(4):339-43. PubMed ID: 2057913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemostatic anomalies and coronary risk].
    de Lorgeril M; Renaud S
    Rev Prat; 1992 Nov; 42(17):2136-40. PubMed ID: 1290035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which patients with coronary artery disease are most prone to develop a coronary artery event (presumably thrombosis)?
    Prentice CR
    Thromb Haemost; 1979 Feb; 41(1):63-72. PubMed ID: 384588
    [No Abstract]   [Full Text] [Related]  

  • 8. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor of coronary heart disease. II. Changes of platelets, fibrinogen and antiplasmins in a group of 2,000 middle aged men (40-60 years) periodically followed up for three years.
    Papilian M; Niţă I
    Med Interne; 1975; 13(4):271-82. PubMed ID: 128813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of several risk factors of atherosclerosis on rheologic properties of the blood].
    Murashko VV; Strutynskiĭ AV; Shabashova NI
    Ter Arkh; 1983; 55(12):19-22. PubMed ID: 6665709
    [No Abstract]   [Full Text] [Related]  

  • 11. The electrophoretic mobility of red cells and platelets and the plasma viscosity in coronary heart disease.
    Karppinen K
    Acta Med Scand Suppl; 1970; 506():1-42. PubMed ID: 5268180
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen as a risk factor for coronary heart disease.
    Montalescot G; Collet JP; Choussat R; Thomas D
    Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension.
    Capuano V; Lamaida N; Mazzotta G; Scotto di Quacquaro G
    G Ital Cardiol; 1998 May; 28(5):530-5. PubMed ID: 9646068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic factors as triggers of cardiovascular events.
    Rosito GB; Tofler GH
    Cardiol Clin; 1996 May; 14(2):239-50. PubMed ID: 8724556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor for coronary heart disease. I. Prevalence of the changes in the blood coagulation-fibrinolysis system in a middle aged male population.
    Papilian M; Niţă I
    Med Interne; 1975; 13(2):95-103. PubMed ID: 128812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease in women.
    Srinivasan KN; Satyamurthy I
    J Assoc Physicians India; 2002 Feb; 50():259-64. PubMed ID: 12038659
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.